Navigation Links
Girls Could Be Vaccinated Against Cervical Cancer in Britain

The British government took a step Wednesday toward offering vaccinations against cervical cancer for girls as young as 12, a measure that could be carried out by late next year. The Joint Committee on Vaccination and Immunisation (JCVI) recommended the use of vaccines to guard against the human papilloma virus (HPV), a sexually transmitted infection which causes most cases of cervical cancer.

The Department of Health said it had agreed "in principle" to accept the body's advice, but would wait for an independent review of the costs to the National Health Service. Cervical cancer kills more than 1,000 women in Britain annually. The vaccinations would be offered to girls throughout Britain, but would not be compulsory.

Currently, there are two vaccines -- Gardasil made by Merck and Sanofi Pasteur and Cervarix made by GlaxoSmithKline -- which are designed to be used in an immunisation programme. Gardasil was introduced to Britain last year. The government has not approved it for use on the National Health Service, although Britain's Press Association news agency said it has been approved in dozens of other countries, including the United States, Canada and Australia.

Cervarix is expected to receive its European Union licence later this year. Public Health Minister Caroline Flint said: "It is great news that vaccines have been developed that protect women against this form of cancer and I am delighted to announce that we intend, in principle, to introduce a HPV vaccine into the national immunisation programme."

"A significant amount of planning is required before we can introduce the immunisation into our programme," she said. "We are still working on the details and logistics, and will work closely with the NHS to ensure the vaccination can be delivered effectively.

However, we are hoping that girls will start being vaccinated from as early as 2008." The department said smear testing would continu e after the vaccine is introduced.


'"/>




Related medicine news :

1. Girls Hit Tanning Booths More Than Boys
2. Suppressing A Girls Height In Adolescence Could Lead to Fertility Problems
3. Vitamin D Supplement in Teenage Girls essential in Winter months
4. Vitamin D Supplement in Teenage Girls essential in Winter months
5. Girls Who Undergo Genital Mutilation Can Become Infertile
6. Boys Suffer More Mathematics Learning Disorder Than Girls
7. Sexually Abused Girls Develop Eating Disorders
8. Teenage Girls May Not Need Parents Consent For Abortion
9. AIDS More Prevalent Among Teenage Girls In The US
10. Half The Girls In UK Starve To Stay Slim
11. HIV Positive Girls Face Boycott
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, ... to its patient care management module. Using this new feature, sleep physicians can ... been initiated on continuous positive airway pressure (CPAP), oral, or other forms of ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place ... to a special report in the May issue of Consumer Reports focused on heart ... ranking for results achieved during and after coronary bypass and aortic valve replacement procedures. ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... the continuation of its strategic partnership with and platinum sponsorship of Global Spine ... the safe and effective management of complex spine deformity cases, particularly in children. ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS Healthcare Solutions debuted ... capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. , BYOD has ... with a pre-programmed tablet in a remarkably easy-to-use kit for patients. “BYOD is ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project ... 2017: Telehealth 2.0 — the American Telemedicine Association’s annual conference, on April 23 in ... for using telemedicine to improve the lives of the poor and underserved in other ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... April 19, 2017 Cardiology devices segment is anticipated ... The Cardiology Devices segment is likely to create ... Mn in 2018 over 2017. By the end of 2027, ... close to US$ 700 Mn, expanding at a CAGR of ... the Asia Pacific reprocessed medical devices ...
Breaking Medicine Technology: